EC Number |
Expression |
Reference |
---|
3.4.23.15 | down |
angiotensin II inhibits renin release from the juxtaglomerular cells in the kidney |
712875 |
3.4.23.15 | down |
angiotensin II inhibits the release of renin from the kidney |
711778 |
3.4.23.15 | down |
chronic sympatho-inhibition with rilmenidine (2.5 mg/kg/day) reduces basal plasma renin activity |
711629 |
3.4.23.15 | down |
renin release from juxtaglomerular cells is inhibited by Ca2+ and calcium-dependent phosphodiesterase 1C |
710820 |
3.4.23.15 | down |
renin-angiotensin-aldosterone system blockade with angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers leads to exacerbated renin release through loss of negative-feedback inhibition |
712922 |
3.4.23.15 | down |
the angiotensin type I receptor 1166C allele in homozygous form is characterized by low plasma renin levels |
712634 |
3.4.23.15 | down |
treatment with 0.05 mg urocortin 2 or 0.05 mg urocortin 2 plus 20 mg furosemide markedly reduces plasma renin activity |
711768 |
3.4.23.15 | more |
the enzyme exhibits low mRNA expression levels in all stages of pre-adipocyte differentiation with no significant transcriptional increase up to day 21 |
753983 |
3.4.23.15 | more |
there are no significant differences in mRNA abundance between salinities or time for the enzyme gene |
753324 |
3.4.23.15 | more |
treatment with 16 mg azelnidipine for 4 weeks does not affect plasma renin activity |
717688 |